Insulin-like growth factor 2 receptor (IGF2R) is overexpressed in OS [194,195], which has been used to develop radiolabeled antibody targeting IGF2R with Indium-111, Lutetium-177 and Bismuth-213 and showing delayed tumor growth in vivo in an OS model [196]. The gene discussed is IGF2R; the disease is neoplasm.